Matthew McCord

7PUBLICATIONS
33CO-AUTHORS
Multiphysics flows (incl. multiphase and reacting flows)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2025
F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma.

Thomas K Sears, Wenxia Wang, Michael Drumm

|Nov 08, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis.

Víctor A Arrieta, Johnny Duerinck, Kirsten B Burdett

|Jul 29, 2023
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review.

Shreya Budhiraja, Hinda Najem, Shashwat Tripathi

|Nov 26, 2022
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts.

Matthew McCord, Elizabeth Bartom, Kirsten Burdett

|Sep 15, 2021
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model.

Amélie Vézina, Monica Manglani, DreeAnna Morris

Pageof 2

Frequent Collaborators

3 joint publications

Craig M Horbinski

2 joint publications

Thomas Sears

2 joint publications

Amy B Heimberger

2 joint publications

Roger Stupp